When the symptoms of psoriatic arthritis (PsA) are severe, doctors often turn to disease-modifying antirheumatic drugs (DMARDs) for treatment. These drugs alleviate the symptoms of psoriatic arthritis as well as slow down or stop joint and tissue damage and the progression of the disease.
DMARDs comprise several classes of medications. Traditionally, they are used to either reduce the body's risk of rejection of a transplanted organ or to treat conditions such as cancer or inflammatory bowel disease. When they are used to treat psoriatic arthritis, the doses are significantly lower and the risk of side effects tends to be considerably less.
The common denominator among all DMARDs is their ability to modify the underlying processes that cause inflammatory conditions such as psoriatic arthritis. They accomplish this feat by altering how the immune system functions. A description of the various types of DMARDs follows.
Chemotherapy Drugs
The most commonly used DMARD is methotrexate. Taken by mouth or injection, it is an immunosuppressive drug approved by the Food and Drug Administration (FDA) for the treatment of psoriasis, but it is also used widely and successfully for treating psoriatic arthritis. Methotrexate has proven effective at relieving the symptoms associated with psoriatic arthritis, and studies suggest it may help prevent joint destruction as well. It works by binding to an enzyme that is involved in the rapid growth of cells.
Copyright 2009 NBC Health
Click here to read the rest of the article at HealthVideo.com
